These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 10958084

  • 1. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.
    Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F.
    Psychopharmacology (Berl); 2000 Jul; 150(4):422-9. PubMed ID: 10958084
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
    Wadenberg ML, Hertel P, Fernholm R, Hygge Blakeman K, Ahlenius S, Svensson TH.
    J Neural Transm (Vienna); 2000 Jul; 107(10):1229-38. PubMed ID: 11129112
    [Abstract] [Full Text] [Related]

  • 3. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG, Browning JL, Young KA, Hicks PB.
    Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
    [Abstract] [Full Text] [Related]

  • 4. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
    Olsen CK, Brennum LT, Kreilgaard M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):318-27. PubMed ID: 18325493
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in rats.
    Jacobson SM, Prus AJ.
    Behav Pharmacol; 2010 Oct 28; 21(7):654-9. PubMed ID: 20729715
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects.
    Wadenberg ML, Soliman A, VanderSpek SC, Kapur S.
    Neuropsychopharmacology; 2001 Nov 28; 25(5):633-41. PubMed ID: 11682246
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
    Wadenberg ML, Salmi P, Jimenez P, Svensson T, Ahlenius S.
    Eur Neuropsychopharmacol; 1996 Nov 28; 6(4):305-10. PubMed ID: 8985714
    [Abstract] [Full Text] [Related]

  • 8. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S, Reckless GE, Nobrega JN, Fletcher PJ, Kapur S.
    Neuropsychopharmacology; 2006 Sep 28; 31(9):1854-63. PubMed ID: 16319908
    [Abstract] [Full Text] [Related]

  • 9. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
    Alcock SJ, Hemsley KM, Crocker AD.
    Eur J Pharmacol; 2001 Jul 27; 424(3):179-87. PubMed ID: 11672560
    [Abstract] [Full Text] [Related]

  • 10. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
    Wadenberg ML, Ahlenius S.
    J Neural Transm Gen Sect; 1991 Jul 27; 83(1-2):43-53. PubMed ID: 1673344
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F, Gründer G, Biziere K, Stephane M, Dogan AS, Dannals RF, Ravert H, Suri A, Bramer S, Wong DF.
    Neuropsychopharmacology; 2002 Aug 27; 27(2):248-59. PubMed ID: 12093598
    [Abstract] [Full Text] [Related]

  • 12. Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
    Wiker C, Schilström B, Sandbäck C, Wadenberg ML, Svensson TH.
    Int J Neuropsychopharmacol; 2008 Sep 27; 11(6):845-50. PubMed ID: 18405415
    [Abstract] [Full Text] [Related]

  • 13. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
    Hertel P, Fagerquist MV, Svensson TH.
    Science; 1999 Oct 01; 286(5437):105-7. PubMed ID: 10506554
    [Abstract] [Full Text] [Related]

  • 14. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T.
    Drug Metab Dispos; 1997 Jun 01; 25(6):675-84. PubMed ID: 9193868
    [Abstract] [Full Text] [Related]

  • 15. An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy.
    Crocker AD, Hemsley KM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 01; 25(3):573-90. PubMed ID: 11370998
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A, Wadenberg ML, Svensson TH.
    Biol Psychiatry; 2005 Aug 15; 58(4):337-43. PubMed ID: 16102547
    [Abstract] [Full Text] [Related]

  • 17. Contrasting loxapine to its isomer isoloxapine--the critical role of in vivo D2 blockade in determining atypicality.
    Natesan S, Vanderspek S, Nobrega JN, McClelland RA, Kapur S.
    Schizophr Res; 2005 Sep 15; 77(2-3):189-99. PubMed ID: 15925489
    [Abstract] [Full Text] [Related]

  • 18. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D.
    Synapse; 2010 Aug 15; 64(8):624-33. PubMed ID: 20340171
    [Abstract] [Full Text] [Related]

  • 19. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC, Cohen M, Coffin VL.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):118-23. PubMed ID: 1830098
    [Abstract] [Full Text] [Related]

  • 20. In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
    Assié MB, Dominguez H, Consul-Denjean N, Newman-Tancredi A.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep 01; 373(6):441-50. PubMed ID: 16947046
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.